The upregulation of immune checkpoints such as PD-L1/PD-1 is a critical characteristic of an inflamed TME, which is driven by pre-infiltrating tumor infiltrating immune cells (TIICs) (64). The gene discussed is PDCD1; the disease is neoplasm.